{"derived":{"adj":{"INE0CZ201":[]},"dividends":{"bridged":false,"first_fy":"FY2026-27","fy":{"FY2026-27":{"adj":2.0,"dps":2.0,"n":1,"paid_cr":112.34,"partial":false}},"fy_dps":null,"fy_last":"FY2025-26","fy_paid_cr":null,"held":0,"last_ex":"2026-06-25","open":true,"paid_ttm_cr":112.34,"payouts":1,"raised":0,"shares_asof":"2026-09-30","shares_out":563897758,"since":"FY2026-27","streak":1,"streak_ended":null,"ttm_dps":2.0,"ttm_n":1,"ttm_partial":false,"years_on_record":1,"yield_fy":null,"yield_ttm":0.21},"dividends_by_fy":{"INE0CZ201":{"FY2026-27":{"distribution":0.0,"final":2.0,"interim":0.0,"n":1,"pct_only":0,"special":0.0,"total":2.0,"unspecified":0.0}}}},"events":[{"announce":null,"bc_from":null,"bc_to":null,"bse_scrip":"544449","class":"equity","confidence":1.0,"detail":"Rs 2 per share","event_id":"INE0CZ201:2026-06-25:dividend:0","ex":"2026-06-25","ex_move":{"move":-0.96,"on":["2026-06-25",761.7],"pre":["2026-06-24",769.1]},"exchanges":["BSE","NSE"],"field_provenance":{"div_amount":"nse_pr_bc","div_pct_fv":"bse_corpact","fv_used":"bse_corpact"},"fields":{"div_amount":2.0,"div_pct_fv":100.0,"fv_used":2.0,"payout_cr":112.34},"flags":["fv_from_counterpart"],"group":"equity","instrument_id":"INE0CZ201020","isin_after":null,"isin_at_event":"INE0CZ201020","issuer_id":"INE0CZ2","lineage":"INE0CZ201","name":"Anthem Biosciences Limited","nd_from":"2026-06-25","nd_to":"2026-06-25","payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-06-11","last_seen":"2026-06-25","purpose":"DIV - RS 2 PER SH","scrip":null,"series":"BE","src":"nse_pr_bc","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-06-11","last_seen":"2026-06-25","purpose":"DIV - RS 2 PER SH","scrip":null,"series":"BL","src":"nse_pr_bc","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-06-11","last_seen":"2026-06-25","purpose":"DIV - RS 2 PER SH","scrip":null,"series":"EQ","src":"nse_pr_bc","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-06-11","last_seen":"2026-06-25","purpose":"DIV - RS 2 PER SH","scrip":null,"series":"IQ","src":"nse_pr_bc","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-09-15","last_seen":"2026-11-12","purpose":"Dividend - Rs 2 Per Share","scrip":null,"series":"EQ","src":"nse_api","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-11-11","last_seen":"2026-11-11","purpose":"Final Dividend - Rs. - 2.0000","scrip":"544449","series":null,"src":"bse_dd","symbol":null},{"ex_from_record":false,"first_seen":"2026-09-11","last_seen":"2026-11-12","purpose":"DP-100%","scrip":"544449","series":null,"src":"bse_corpact","symbol":null}],"record":"2026-06-26","series":"BE","sources":["nse_pr_bc","nse_api","bse_dd","bse_corpact"],"subtype":"final","symbol":"ANTHEM","type":"dividend"},{"announce":"2026-10-28","bc_from":null,"bc_to":null,"bse_scrip":"544449","class":"equity","confidence":1.0,"detail":"Financial results for the period ended Sep 2026","event_id":"INE0CZ201:2026-11-03:meeting:0","ex":"2026-11-03","exchanges":["BSE","NSE"],"field_provenance":{"agenda":"nse_bm","attachment":"nse_bm","period":"nse_bm"},"fields":{"agenda":["results"],"attachment":"https://nsearchives.nseindia.com/corporate/xbrl/PRIOR_INTIMATION_25167_WebXMLFile_20261028_124940989.xml","period":"2026-09"},"flags":[],"group":"equity","instrument_id":"INE0CZ201020","isin_after":null,"isin_at_event":"INE0CZ201020","issuer_id":"INE0CZ2","lineage":"INE0CZ201","name":"Anthem Biosciences Limited","nd_from":null,"nd_to":null,"payment":null,"price_adjust":false,"qtychange":false,"raw":[{"ex_from_record":false,"first_seen":"2026-10-28","last_seen":"2026-11-12","purpose":"BOARD MEETING: Board Meeting Intimation | Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .","scrip":null,"series":"EQ","src":"nse_bm","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-10-28","last_seen":"2026-11-12","purpose":"BOARD MEETING: Financial Results | To consider and approve the financial results for the period ended September 30, 2026","scrip":null,"series":"EQ","src":"nse_bm","symbol":"ANTHEM"},{"ex_from_record":false,"first_seen":"2026-10-30","last_seen":"2026-11-12","purpose":"BOARD MEETING: Quarterly Results","scrip":"544449","series":null,"src":"bse_bm","symbol":null}],"record":null,"series":"EQ","sources":["nse_bm","bse_bm"],"subtype":"board","symbol":"ANTHEM","type":"meeting"}],"instruments":[{"bse":["544449"],"class":"equity","coupon_pct":null,"coupon_src":null,"frequency":null,"isin":"INE0CZ201020","last_event":"2026-11-03","maturity":null,"n_events":2,"name":"Anthem Biosciences Limited","next_event":null,"nse":["ANTHEM"],"status":"listed","symbol":"ANTHEM","ticker":"ANTHEM"}],"issuer":{"bse_scrips":["544449"],"bse_tickers":["ANTHEM"],"classes":{"equity":1},"delisted_on":null,"equity_isins":["INE0CZ201020"],"file":"INE0CZ2","first_year":"2026","industry":"Pharmaceuticals & Biotechnology","issuer_id":"INE0CZ2","last_seen":"2026-11-12","last_year":"2026","mse_listed":false,"mse_symbols":["ANTHEM"],"n_events":2,"n_instruments":1,"name":"Anthem Biosciences Limited","names":["Anthem Biosciences Limited"],"next_ex":null,"nse_symbols":["ANTHEM"],"px":true,"sector":"Healthcare","slug":"ANTHEM","status":"listed"}}